Gp22 has been awfully quiet is that good or bad. What is bad and continues is the real lack of volume and the ongoing inability for this company to get Wall Street involved. Certainly there are abilities this company has had to get some big box companies on board.Some publications have us in the same vein as the very top CBD names. The Company does good marketing but there are no real money people backing this stock as evidence of a reverse split going nowhere but south.